Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells
- PMID: 17522055
- DOI: 10.1074/jbc.M701978200
Regulation of FOXO3a/beta-catenin/GSK-3beta signaling by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in prostate cancer cells
Erratum in
- J Biol Chem. 2013 Nov 29;288(48):34755
Abstract
Previous studies from our laboratory have shown anti-proliferative and pro-apoptotic effects of 3,3'-diindolylmethane (DIM) through regulation of Akt and androgen receptor (AR) in prostate cancer cells. However, the mechanism by which DIM regulates Akt and AR signaling pathways has not been fully investigated. It has been known that FOXO3a and glycogen synthase kinase-3beta (GSK-3beta), two targets of activated Akt, interact with beta-catenin, regulating cell proliferation and apoptotic cell death. More importantly, FOXO3a, GSK-3beta, and beta-catenin are all AR coregulators and regulate the activity of AR, mediating the development and progression of prostate cancers. Here, we investigated the molecular effects of B-DIM, a formulated DIM with higher bioavailability, on Akt/FOXO3a/GSK-3beta/beta-catenin/AR signaling in hormone-sensitive LNCaP and hormone-insensitive C4-2B prostate cancer cells. We found that B-DIM significantly inhibited the phosphorylation of Akt and FOXO3a and increased the phosphorylation of beta-catenin, leading to the inhibition of cell growth and induction of apoptosis. We also found that B-DIM significantly inhibited beta-catenin nuclear translocation. By electrophoretic mobility shift and chromatin immunoprecipitation assays, we found that B-DIM inhibited FOXO3a binding to the promoter of AR and promoted FOXO3a binding to the p27(KIP1) promoter, resulting in the alteration of AR and p27(KIP1) expression, the inhibition of cell proliferation, and the induction of apoptosis in both androgen-sensitive and -insensitive prostate cancer cells. These results suggest that B-DIM-induced cell growth inhibition and apoptosis induction are partly mediated through the regulation of Akt/FOXO3a/GSK-3beta/beta-catenin/AR signaling. Therefore, B-DIM could be a promising non-toxic agent for possible treatment of hormone-sensitive but most importantly hormone-refractory prostate cancers.
Similar articles
-
Regulation of Akt/FOXO3a/GSK-3beta/AR signaling network by isoflavone in prostate cancer cells.J Biol Chem. 2008 Oct 10;283(41):27707-27716. doi: 10.1074/jbc.M802759200. Epub 2008 Aug 7. J Biol Chem. 2008. PMID: 18687691 Free PMC article.
-
Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.Cancer Res. 2006 Oct 15;66(20):10064-72. doi: 10.1158/0008-5472.CAN-06-2011. Cancer Res. 2006. Retraction in: Cancer Res. 2018 Sep 15;78(18):5473. doi: 10.1158/0008-5472.CAN-18-1167. PMID: 17047070 Retracted.
-
Cell cycle-dependent effects of 3,3'-diindolylmethane on proliferation and apoptosis of prostate cancer cells.J Cell Physiol. 2009 Apr;219(1):94-9. doi: 10.1002/jcp.21650. J Cell Physiol. 2009. PMID: 19062173 Free PMC article.
-
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.J Cell Biochem. 2006 Oct 1;99(2):402-10. doi: 10.1002/jcb.20983. J Cell Biochem. 2006. PMID: 16741972 Review.
-
The duality of GSK-3β in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways.Biochim Biophys Acta Rev Cancer. 2025 Jul;1880(3):189324. doi: 10.1016/j.bbcan.2025.189324. Epub 2025 Apr 19. Biochim Biophys Acta Rev Cancer. 2025. PMID: 40258445 Review.
Cited by
-
Isotretinoin and FoxO1: A scientific hypothesis.Dermatoendocrinol. 2011 Jul;3(3):141-65. doi: 10.4161/derm.3.3.15331. Epub 2011 Jul 1. Dermatoendocrinol. 2011. PMID: 22110774 Free PMC article.
-
FOXO3a and Its Regulators in Prostate Cancer.Int J Mol Sci. 2021 Nov 20;22(22):12530. doi: 10.3390/ijms222212530. Int J Mol Sci. 2021. PMID: 34830408 Free PMC article. Review.
-
Mechanisms and therapeutic implications of cell death induction by indole compounds.Cancers (Basel). 2011 Jul 19;3(3):2955-74. doi: 10.3390/cancers3032955. Cancers (Basel). 2011. PMID: 24212940 Free PMC article.
-
3,3'-Diindolylmethane stimulates exosomal Wnt11 autocrine signaling in human umbilical cord mesenchymal stem cells to enhance wound healing.Theranostics. 2017 Apr 10;7(6):1674-1688. doi: 10.7150/thno.18082. eCollection 2017. Theranostics. 2017. PMID: 28529644 Free PMC article.
-
OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins.Trends Mol Med. 2008 May;14(5):219-27. doi: 10.1016/j.molmed.2008.03.002. Epub 2008 Apr 9. Trends Mol Med. 2008. PMID: 18403263 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous